Inherent Suppression of Thyroid Stimulating Hormone in Newly Diagnosed Dyslipidemic Patients – Indication for Use of Thyromimetics?

Background: Dyslipidemia triggers a sequel of metabolic derangements such as insulin resistance, hyperglycemia and oxidative stress via vicious cycle. Dyslipidemia is characterised by elevation of plasma cholesterol, triglycerides (TGs), or both, or a low level of high-density lipoprotein (HDL) whic...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Clin Diagn Res
Egile Nagusiak: Udupa, Sridevi V., D’Souza, Vivian, Udupa, Vinit A., Manjrekar, Poornima A.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: JCDR Research and Publications (P) Limited 2014
Gaiak:
Biochemistry Section
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4225880/
https://ncbi.nlm.nih.gov/pubmed/25386428
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7860/JCDR/2014/10363.4905
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak